Skip to content
2000
Volume 1, Issue 2
  • ISSN: 1872-3128
  • E-ISSN: 1874-0758

Abstract

The metabolism of (-)-deprenyl (N-methyl,N-propargylamphetamine) and N-methyl,N-propargylphenylethylamine (MPPE), monoamine oxidase inhibitors with neuroprotective properties, was studied using human liver microsomes and cDNA-expressed cytochrome P450 (CYP) enzymes. The metabolic pathways of MPPE parallel those of (-)- deprenyl, but some marked differences were observed, particularly with regard to the contributions of CYP2B6 and CYP2D6.

Loading

Article metrics loading...

/content/journals/dml/10.2174/187231207780363589
2007-04-01
2025-10-11
Loading full text...

Full text loading...

/content/journals/dml/10.2174/187231207780363589
Loading

  • Article Type:
    Research Article
Keyword(s): amphetamine; cDNA; CYP2B6; Metabolism; propargylamphetamine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test